24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Resources
Basic InformationLookupsLatest News
Cataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureOdds for Death, Hospital Care Rise When Statins Are StoppedWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study FindsCOVID Antibody Treatment Is Safe, Effective in Transplant PatientsThere Is No 'Healthy Obesity,' Study FindsExpiration Dates on Johnson & Johnson COVID Vaccine ExtendedWill People Really Need a Yearly COVID Booster Vaccine?America Is Losing the War Against DiabetesGene Editing Technique Corrects Sickle Cell Disease in MiceCOVID Vaccines Appear Safe for People With IBDNew Treatment Fights Rare Cases of Vaccine-Linked Blood ClotsWoman Dies From Dengue Fever Acquired in FloridaAstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood PlateletsWhy a COVID Diagnosis Could Cost You Way More Money in 2021New Links Between Poor Sleep, Diabetes and DeathVaccinations More Urgent as Variant That Crippled India Shows Up in the U.S.Think You Can Skip That Annual Physical?  Think AgainReal-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVIDDeath Rates Are Rising Across Rural AmericaWhat Diet Is Most Likely to Help Ease Crohn's Disease?'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant PatientsYour Teen's Smartphone Could Be Key to Unhealthy WeightToo Much Caffeine Might Raise Your Odds for GlaucomaPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsStudy Pinpoints Cancer Patients at Highest Risk From COVIDMany Existing Drugs Could Be Potent COVID Fighters: StudyAntibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyNew Disabilities Plague Half of COVID Survivors After Hospital DischargeDeclining Vaccination Rates Threaten Biden's July 4 GoalYour Doctor Appointments Might Look Different Post-PandemicPrior COVID Infection May Shield You From Another for at Least 10 MonthsTeens: You Got Your COVID Vaccine, What Now?White House Lists Countries Getting First Batch of Extra COVID VaccinesStrokes Hitting COVID Patients Are More Severe: StudyAverage COVID Hospital Bill for U.S. Seniors Nearly $22,000Deep Brain Stimulation Therapy May Help Parkinson's Patients Long TermNIH Starts Trial Assessing 'Mix & Match' COVID Vaccine ApproachAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsGlobal Warming to Blame for 1 in 3 Heat-Related Deaths WorldwideBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the WayU.S. Set to Send Millions of COVID Vaccines to Countries in NeedAs Teen, He Made News Opposing Anti-Vax Mom. Now, He's Urging COVID Shots for Youth
Questions and AnswersLinks
Related Topics

Diabetes

'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant Patients

HealthDay News
by Ernie Mundell
Updated: Jun 8th 2021

new article illustration

TUESDAY, June 8, 2021 (HealthDay News) -- New research suggests that many people who've undergone an organ transplant do not get an immune response from COVID-19 vaccines that's strong enough to ward off a "breakthrough" infection.

In a new review of 14 such cases, these breakthrough COVID-19 infections occurred in 10 recipients of new kidneys, two liver recipients, one lung recipient and one heart recipient, said a research team working in New York City.

Eight of them had completed the Pfizer COVID-19 two-dose vaccine series, five had completed the Moderna two-dose series and one had gotten the Johnson & Johnson single-dose vaccine, according to the team from NYU Langone.

"We need additional studies to determine why these breakthrough cases may be occurring and how to prevent them, but also want to ensure that transplant patients continue to take all the proper precautions that have been protecting them through the pandemic," Dr. Robert Montgomery, director of the hospital's Transplant Institute, said in a Langone news release.

Transplant patients typically take immune-suppressing drugs after receiving a donor organ, to help ward off organ rejection. But it's thought that use of the drug could have a side-effect of rendering vaccines less effective.

All of the patients in the new study were taking various immunosuppressant drugs including: prednisone, calcineurin inhibitor (13), antimetabolite agent (13), belatacept (1) and mTOR inhibitor (1), Montgomery's team noted.

Seven patients were hospitalized after their breakthrough infections, with five patients developing severe COVID-19 illness.

The heart transplant recipient, who was among those who developed severe COVID-19, died, according to the study published online recently in the journal Transplantation.

"These are troubling findings for transplant patients who may think they are protected after being fully vaccinated," Montgomery said.

The trials that led up to approval of COVID-19 vaccines had "excluded immunocompromised patients," according to study co-author Dr. Sapna Mehta, an infectious disease specialist and clinical director of the institute.

Furthermore, "a recent report found only 17% of transplant recipients had any detectable anti-spike antibodies after the first mRNA vaccine compared to 100% of non-immunocompromised patients having antibody responses in clinical trials," she said.

Anti-spike refers to the "spike protein" on the SARS-CoV-2 coronavirus that is the prime target of approved vaccines.

"Further follow-up of the same cohort of transplant recipients shows antibody responses improved to 54% after their second vaccine dose," Mehta said, but that level is still "far below response rates in non-immunocompromised patients."

Mehta noted that there are 10 million Americans with compromised immune systems.

More study is needed to determine the best vaccine dosages for these people, "who continue to live under heightened pandemic precautions while their level of vaccine-related immunity remains uncertain," Mehta said.

More information

The American Society of Transplantation has more on COVID-19.

SOURCE: NYU Langone Health, news release, May 2021